KDM6B (also known as JMJD3) has been implicated as an epigenetic regulator in metabolic disorders, including NAFLD, and could specifically serve as a demethylase of histone H3K27. This evidence concerns the gene KDM6B and metabolic dysfunction-associated steatotic liver disease.